Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fuad El-Hibri Insider Profile
4 Followers
Fuad El-Hibri, Director at Emergent Biosolutions, holds 1.34M shares in Emergent Biosolutions (Ticker: EBS), holds 87.70K shares in Aptevo Therapeutics (Ticker: APVO).
Profitable Transactions
0 out of 10 Profitable Transactions
Average Return
-41.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Fuad El-Hibri holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 30, 2019 - Jul 30, 2020
Return:-29.20%
The most profitable trade made by Fuad El-Hibri
Fuad El-Hibri's Trading History
Emergent Biosolutions
Dec 07, 2021
Director
Uninformative Buy
―
$2.90M
Aptevo Therapeutics
Dec 07, 2021
Director
Uninformative Buy
―
$62.26K
List of latest transactions for each holding click on a transaction to see Fuad El-Hibri's performance on stock
You May Also Like
Fuad El-Hibri insider profile FAQ
What is the percentage of profitable transactions made by Fuad El-Hibri?
The percentage of profitable transactions made by Fuad El-Hibri is 0%.
What is the average return per transaction made by Fuad El-Hibri?
The average return per transaction made by Fuad El-Hibri is -41.00%.
What stocks does Fuad El-Hibri hold?
Fuad El-Hibri holds: EBS, APVO stocks.
What was Fuad El-Hibri’s latest transaction?
Fuad El-Hibri latest transaction was an Uninformative Buy of ―.
What was Fuad El-Hibri's most profitable transaction?
Fuad El-Hibri’s most profitable transaction was an Informative Buy of APVO stock on July 30, 2019. The return on the trade was -29.20%.
What is Fuad El-Hibri's role in Emergent Biosolutions?
Fuad El-Hibri's role in Emergent Biosolutions is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.